Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
2.555 USD | +2.61% | +8.94% | -37.41% |
02/05 | Organogenesis Achieves Primary Endpoint in Phase 3 Clinical Trial of ReNu for Knee Osteoarthritis | CI |
29/02 | Transcript : Organogenesis Holdings Inc., Q4 2023 Earnings Call, Feb 29, 2024 |
Quotes 5-day view
Delayed Quote Nasdaq29/04/2024 | 30/04/2024 | 01/05/2024 | 02/05/2024 | 03/05/2024 | |
---|---|---|---|---|---|
Last | 2.455 $ | 2.35 $ | 2.51 $ | 2.49 $ | 2.555 $ |
Volume | 1 037 126 | 263 990 | 462 786 | 3 006 636 | 475 258 |
Change | +4.47% | -4.28% | +6.81% | -0.80% | +2.61% |
Opening | 2.35 | 2.41 | 2.38 | 2.68 | 2.48 |
High | 2.49 | 2.44 | 2.57 | 2.92 | 2.64 |
Low | 2.32 | 2.35 | 2.36 | 2.42 | 2.455 |
Performance
1 day | +2.61% | ||
1 week | +8.94% | ||
Current month | +8.94% | ||
1 month | -7.58% | ||
3 months | -20.00% | ||
6 months | +8.02% | ||
Current year | -37.41% | ||
1 year | +24.27% | ||
3 years | -88.98% | ||
5 years | -65.87% |
Volumes
marketsBasic data
Highs and lows
Indicators
Sector Comparison - Other Biotechnology & Medical Research
Name | Change | 5d. change | 1st Jan change | 1-year change | Capi. | |
---|---|---|---|---|---|---|
+2.61% | +8.94% | -37.41% | +24.27% | 330M | ||
-2.62% | +13.79% | +23.54% | -5.59% | 48.09B | ||
+1.09% | -1.55% | +46.90% | -10.72% | 40.62B | ||
+0.92% | -4.71% | -3.27% | +19.68% | 40.43B | ||
+0.80% | +6.54% | -6.20% | +17.83% | 28.36B | ||
+2.81% | +0.05% | +8.97% | +66.05% | 24.89B | ||
+1.78% | +6.64% | -20.16% | -23.40% | 19.01B | ||
+1.30% | -0.40% | +28.64% | +91.91% | 12.09B | ||
+2.48% | +21.00% | +0.45% | -9.85% | 11.88B | ||
+1.86% | +2.00% | -1.18% | +22.01% | 11.8B | ||
+0.97% | +11.34% | +18.41% | +19.22% | 11.45B | ||
+0.94% | +3.31% | -3.89% | -7.12% | 9.47B | ||
+0.90% | +15.87% | +16.83% | +107.71% | 6.72B | ||
+0.82% | +9.59% | +37.41% | +65.38% | 6.68B | ||
-0.94% | +11.51% | +7.53% | -35.02% | 6.62B | ||
+1.64% | -0.92% | +23.62% | -16.39% | 6.49B | ||
Average | +1.12% | +6.84% | +8.76% | +20.37% | ||
Weighted average by Cap. | +0.69% | +5.78% | +12.76% | +14.16% |
Historical data
Date | Opening | High | Low | End-of-day | Volume |
---|
Last transactions
Date | Price | Volume | Daily volume |
---|---|---|---|
10:55:45 pm | 2.555 | 100 | 416,140 |
10:54:32 pm | 2.56 | 100 | 416,040 |
10:54:32 pm | 2.56 | 100 | 415,940 |
10:54:32 pm | 2.56 | 100 | 415,840 |
10:54:32 pm | 2.56 | 100 | 415,740 |
10:54:32 pm | 2.56 | 100 | 415,640 |
10:54:32 pm | 2.56 | 140 | 415,540 |
10:54:32 pm | 2.56 | 100 | 415,400 |
10:54:32 pm | 2.56 | 224 | 415,300 |
10:54:32 pm | 2.56 | 176 | 415,076 |
Monthly variations
Annual change
2024 | -39.12% | ||
2023 | +52.04% | ||
2022 | -70.89% | ||
2021 | +22.71% | ||
2020 | +56.55% | ||
2019 | -64.21% |
- Stock Market
- Equities
- ORGO Stock
- Quotes Organogenesis Holdings Inc.